113 related articles for article (PubMed ID: 7970083)
1. Treatment of nephrotic syndrome with cyclosporin A. What remains in 1994?
Meyrier A
Nephrol Dial Transplant; 1994; 9(6):596-8. PubMed ID: 7970083
[No Abstract] [Full Text] [Related]
2. [Indications for cyclosporin in the treatment of idiopathic nephrotic syndrome in adults].
Zietse R; Weimar W
Ned Tijdschr Geneeskd; 1992 Sep; 136(36):1749-53. PubMed ID: 1407123
[No Abstract] [Full Text] [Related]
3. Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome.
Zietse R; Wenting GJ; Kramer P; Schalekamp MA; Weimar W
Clin Sci (Lond); 1992 Jun; 82(6):641-50. PubMed ID: 1320544
[TBL] [Abstract][Full Text] [Related]
4. [Advances in the treatment of adult nephrotic syndrome].
Yokoyama H; Asaka M; Yamaya H; Wada T
Nihon Jinzo Gakkai Shi; 2007; 49(2):108-12. PubMed ID: 17375618
[No Abstract] [Full Text] [Related]
5. Cyclosporine treatment of glomerular diseases.
Klein M; Radhakrishnan J; Appel G
Annu Rev Med; 1999; 50():1-15. PubMed ID: 10073260
[TBL] [Abstract][Full Text] [Related]
6. [Effect of cyclosporin A on renal function in patients with glomerulonephritis].
Heering P; Schneider A; Grabensee B; Plum J
Dtsch Med Wochenschr; 2001 Oct; 126(40):1093-8. PubMed ID: 11588659
[TBL] [Abstract][Full Text] [Related]
7. Pefloxacin as first-line treatment in nephrotic syndrome.
Ginsburg C; Toledano D; Deray G; Vlassopoulos D; Baumelou A; Jacobs C
Nephrol Dial Transplant; 1994; 9(3):335. PubMed ID: 8052452
[No Abstract] [Full Text] [Related]
8. Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study.
Yamamoto R; Imai E; Maruyama S; Yokoyama H; Sugiyama H; Nitta K; Tsukamoto T; Uchida S; Takeda A; Sato T; Wada T; Hayashi H; Akai Y; Fukunaga M; Tsuruya K; Masutani K; Konta T; Shoji T; Hiramatsu T; Goto S; Tamai H; Nishio S; Shirasaki A; Nagai K; Yamagata K; Hasegawa H; Yasuda H; Ichida S; Naruse T; Fukami K; Nishino T; Sobajima H; Tanaka S; Akahori T; Ito T; Yoshio T; Katafuchi R; Fujimoto S; Okada H; Ishimura E; Kazama JJ; Hiromura K; Mimura T; Suzuki S; Saka Y; Sofue T; Suzuki Y; Shibagaki Y; Kitagawa K; Morozumi K; Fujita Y; Mizutani M; Shigematsu T; Kashihara N; Sato H; Matsuo S; Narita I; Isaka Y
Clin Exp Nephrol; 2018 Dec; 22(6):1266-1280. PubMed ID: 29679356
[TBL] [Abstract][Full Text] [Related]
9. Which children with nephrotic syndrome benefit from cyclosporin A or cyclophosphamide?
Coulthard MG
Pediatr Nephrol; 2009 Jun; 24(6):1257; author reply 1259. PubMed ID: 19189132
[No Abstract] [Full Text] [Related]
10. Pharmacologic management of adult idiopathic nephrotic syndrome.
Alaniz C; Brosius FC; Palmieri J
Clin Pharm; 1993 Jun; 12(6):429-39. PubMed ID: 8403814
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of primary glomerular diseases. Membranous nephropathy, focal segmental glomerulosclerosis and IgA nephropathy.
Deegens JK; Wetzels JF
Minerva Urol Nefrol; 2005 Sep; 57(3):211-36. PubMed ID: 15986018
[TBL] [Abstract][Full Text] [Related]
12. Benefit and cost from the long-term use of cyclosporine-A in idiopathic membranous nephropathy.
Kalliakmani P; Koutroulia E; Sotsiou F; Vlachojannis JG; Goumenos DS
Nephrology (Carlton); 2010 Dec; 15(8):762-7. PubMed ID: 21175962
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporin therapy for steroid resistant nephrotic focal glomerulosclerosis.
Windom HH; Fisher M; Neale TJ
N Z Med J; 1990 Mar; 103(886):125-6. PubMed ID: 2320338
[TBL] [Abstract][Full Text] [Related]
14. [Successful treatment of a rare variant of mesangioproliferative glomerulonephritis with IgM deposits with Cyclosporin A].
Gurova DV; Chebotareva NV; Vinogradov AA; Stavrovskaya EV; Lysenko LV
Ter Arkh; 2020 Jul; 92(6):73-75. PubMed ID: 33346496
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial of low-dose prednisone and ciclosporin versus high-dose prednisone in nephrotic syndrome of children.
Tejani A; Suthanthiran M; Pomrantz A
Nephron; 1991; 59(1):96-9. PubMed ID: 1944755
[TBL] [Abstract][Full Text] [Related]
16. Japanese clinical practice patterns of primary nephrotic syndrome 2021: a web-based questionnaire survey of certified nephrologists.
Wada T; Shimizu S; Koizumi M; Sofue T; Nishiwaki H; Sasaki S; Nakaya I; Oe Y; Ishimoto T; Furuichi K; Okada H; Kurita N
Clin Exp Nephrol; 2023 Sep; 27(9):767-775. PubMed ID: 37310570
[TBL] [Abstract][Full Text] [Related]
17. Primary nephrotic syndrome in Arab children in Kuwait.
Zaki M; Helin I; Manandhar DS; Hunt MC; Khalil AF
Pediatr Nephrol; 1989 Apr; 3(2):218-20; discussion 221. PubMed ID: 2642101
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporin and prednisolone: do they prevent recurrence of focal segmental glomerulosclerosis?
Burke JR; Rigby RJ
Nephron; 1986; 43(3):236-7. PubMed ID: 3523270
[No Abstract] [Full Text] [Related]
19. Cyclosporine in idiopathic nephrotic syndrome.
Ponticelli C
Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):479-89. PubMed ID: 8227973
[TBL] [Abstract][Full Text] [Related]
20. Decreased hospitalization and increased height velocity in focal segmental glomerulosclerosis responsive to ciclosporin A.
O'Regan S; Murphy GF; Robitaille P; Russo P; Klassen J
Child Nephrol Urol; 1991; 11(4):185-9. PubMed ID: 1777897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
